No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

byKathleen Lau

May 27, 2022

in StudyGraphics

Reading Time: 1 min read

Medical cannabis provides little improvement to sleep in chronic pain patients

RelatedReports

Variation noted across pre- and post-marketing studies for FDA approved devices

Pharma

FDA warns Novo Nordisk over safety reporting violations

April 6, 2026

Significant reduction in prostate screening rates after revised guidelines

Rheumatology

Utility of long-term routine laboratory toxicity monitoring of immunomodulatory drugs in rheumatoid arthritis

August 28, 2025

Shared decision-making may be limited in PICU end-of-life discussions

Public Health

Poor communication closely associated with patient safety incidents

April 15, 2025

Many new pediatric asthma cases attributable to obesity

Endocrinology

Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss

January 7, 2025

Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis

2 Minute Medicine Rewind May 30, 2022

Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain

Shift workers may have increased sleep disruption and use of sleep medication

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

FDA warns Novo Nordisk over safety reporting violations

Utility of long-term routine laboratory toxicity monitoring of immunomodulatory drugs in rheumatoid arthritis

Poor communication closely associated with patient safety incidents

Medical cannabis provides little improvement to sleep in chronic pain patients

2 Minute Medicine Rewind May 30, 2022

RelatedReports

FDA warns Novo Nordisk over safety reporting violations

Utility of long-term routine laboratory toxicity monitoring of immunomodulatory drugs in rheumatoid arthritis

Poor communication closely associated with patient safety incidents

Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss

2 Minute Medicine Rewind May 30, 2022

Shift workers may have increased sleep disruption and use of sleep medication

New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

RELATED REPORTS

Medical cannabis provides little improvement to sleep in chronic pain patients

2 Minute Medicine Rewind May 30, 2022

RelatedReports

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits